A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Clinical trial NCT03616912 · TERMINATED

Trial details

NCT number: NCT03616912
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2018-08-02
Primary completion: 2021-11-01
Enrollment: 830

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.